CUPR — Cuprina Holdings (Cayman) Share Price
Last trade - 00:00- $103.10m
- $103.06m
- SG$0.10m
- 11
- 20
- 47
- 14
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1,582.03 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -1469.51% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | n/a | n/a | 0.06 | 0.06 | 0.1 | n/a | n/a | 31.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company. The Company is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sectors. The Company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy (MDT), which is an alternative to surgical debridement. It also offers two lines of chronic wound care products in its pipeline. Such lines of pipeline chronic wound care products include Collagen dressings, including sponges, particles and hydrogels utilizing bullfrog collagen derived from the valorization of abattoir waste streams of American bullfrogs (Lithobates catesbeianus), and Products utilizing medical leeches for wound treatment.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- September 22nd, 2023
- Public Since
- April 10th, 2025
- No. of Employees
- 14
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 21,750,000
- Address
- Block 1090, Lower Delta Road, #06-08, SINGAPORE, 169201
- Web
- https://cuprina.com/
- Phone
- Auditors
- /s/ Kreit & Chiu CPA’s LLP
Similar to CUPR
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Akari Therapeutics
NASDAQ Capital Market
Akebia Therapeutics
NASDAQ Capital Market
ASP Isotopes
NASDAQ Capital Market
FAQ
As of Today at 20:07 UTC, shares in Cuprina Holdings (Cayman) are trading at $4.74. This share price information is delayed by 15 minutes.
Shares in Cuprina Holdings (Cayman) last closed at $4.74 and the price had moved by over the past 365 days. In terms of relative price strength the Cuprina Holdings (Cayman) share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreCuprina Holdings (Cayman) does not currently pay a dividend.
Cuprina Holdings (Cayman) does not currently pay a dividend.
Cuprina Holdings (Cayman) does not currently pay a dividend.
To buy shares in Cuprina Holdings (Cayman) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $4.74, shares in Cuprina Holdings (Cayman) had a market capitalisation of $103.10m.
Here are the trading details for Cuprina Holdings (Cayman):
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: CUPR
Based on an overall assessment of its quality, value and momentum Cuprina Holdings (Cayman) is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cuprina Holdings (Cayman). Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $4.74, shares in Cuprina Holdings (Cayman) were trading +2.66% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cuprina Holdings (Cayman) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.74.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Cuprina Holdings (Cayman)'s directors